Gas Sensor Market Expected To Trigger A Revenue To USD 4.49 Billion By 2028

 Gas Sensor Market Growth & Trends

The global gas sensor market size is expected to reach USD 4.49 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.7% from 2021 to 2028. The growth can be attributed to the growing demand for gas sensors to monitor gas emissions from industrial facilities. The increasing demand for wearable gas sensors for human health and environmental monitoring also bodes well for the growth of the market over the forecast period.

Various government bodies worldwide are imposing limits on vehicular emissions to curb atmospheric pollution and enhance fuel efficiency. For instance, the U.S. Environmental Protection Agency (EPA) and the National Highway Traffic Safety Administration revised the Corporate Average Fuel Economy targets and the greenhouse gas emission standards for passenger cars in April 2020. The need to abide by the newer emission standards is expected to trigger the demand for gas sensors over the forecast period.

Deteriorating air quality, particularly in urban areas, is a major problem in most parts of the world. Several people worldwide are suffering from various health disorders due to harmful gases emitted from vehicles and industrial facilities. At this juncture, gas sensors can potentially help in assessing the levels of carbon monoxide, carbon dioxide, and other gases in the air and contribute favorably to curbing air pollution.

The outbreak of the COVID-19 pandemic is anticipated to create new opportunities for the market players. The demand for carbon dioxide gas sensors is expected to increase significantly in particular. Carbon dioxide gas sensors are being used widely in European countries for monitoring the indoor environment in schools to control the spread of coronavirus. Guidelines published by the Federation of European Heating, Ventilation, and Air Conditioning Associations also recommend installing carbon dioxide monitoring systems in schools.

Request a free sample copy or view report summary: Gas Sensor Market Report

Gas Sensor Market Report Highlights

• The oxygen sensor segment is expected to witness significant growth over the forecast period. The increasing adoption of oxygen gas sensors in medical equipment is expected to drive the growth of the segment
• The demand for wireless gas sensors is rising owing to the benefits, such as ease of installation and flexibility, associated with wireless devices
• The demand for electrochemical gas sensors is rising owing to the ability of these sensors to detect harmful gas emissions and help in improving air quality
• The increasing number of smart cityprojects being rolled out worldwide are driving the demand for IoT enabled gas sensors for monitoring environmental gas
• Rapid urbanization in emerging economies, such as China and India, is expected to create growth opportunities for the Asia Pacific regional market

Gas Sensor Market Segmentation

Grand View Research has segmented the global gas sensor market based on product, type, technology, end use, and region:

Product Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

• Oxygen (O2)/Lambda Sensors
• Carbon Dioxide (CO2) Sensors
• Carbon Monoxide (CO) Sensors
• Nitrogen Oxide (NOx) Sensors
• Methyl Mercaptan Sensors
• Others (Hydrogen, Ammonia, Hydrogen Sulfide)

Type Outlook (Revenue, USD Million, 2016 - 2028)

• Wireless
• Wired

Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Electrochemical
• Semiconductor
• Solid State/MOS
• Photo-Ionization Detector (PID)
• Catalytic
• Infrared (IR)
• Others

End-use Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

• Medical
• Building Automation & Domestic Appliances
• Environmental
• Petrochemical
• Automotive
• Industrial
• Agriculture
• Others

Regional Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• South America
  • Brazil
• Middle East & Africa

List of Key Players of Gas Sensor Market

• ABB
• AlphaSense Inc.
• City Technology Ltd.
• Dynament
• Figaro Engineering Inc.
• Membrapor
• Nemoto & Co. Ltd.
• Robert Bosch LLC
• Siemens
• GfG Gas Detection UK Ltd.
• FLIR Systems, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Insurtech Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 Insurtech Market Growth & Trends

The global insurtech market size is expected to reach USD 60.98 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 48.8% from 2021 to 2028. The market growth can be attributed to the increasing need to understand the behavior of policyholders. The insurtech solutions and services are widely used by insurance companies to build the with insureds.

The increasing adoption of predictive analytics and data analytics to provide effective customer experiences is expected to fuel the market growth. Numerous insurance companies are adopting these analytics services in various areas, such as fraud identification and claim triage. These services enable insurance companies to prioritize claim management applications.

Artificial Intelligence (AI)-driven analytics services are helping insurers to process their claims in a very short time. These services are acting as a preventative measure against human errors, delays, and consumer dissatisfaction. Moreover, insurers are using external data sources and adding specifics about a claimant from images and social media channels.

The outbreak of the COVID-19 pandemic is expected to favorably impact the market. The pandemic has driven the sense of urgency for insurance companies of all sizes to hasten their digital transformation operations and collaborate with their partners who were their former competitors. The digital transformation is expected to help insurance companies in reducing operating costs, shielding themselves from forthcoming crisis disruption, and serving customers seamlessly.

Request a free sample copy or view report summary: Insurtech Market Report

Insurtech Market Report Highlights

• The increasing awareness about healthy lifestyle habits across the globe is expected to create growth opportunities for insurance companies in the health domain
• Increasing usage of intelligent machines and the rise of automation in the field of insurtech are expected to propel the adoption of managed services in various end-use industries
• The blockchain technology segment is expected to witness significant growth over the forecast period. The segment growth can be attributed to the rising adoption of this technology to reduce fraudulent claims in the insurance industry. This technology also helps insurance companies reduce operational costs of reinsurers and allows them to collect verified real-time data from insurers
• Political and consumer trends are forcing the healthcare industry to become more transparent about pricing, and with startups pioneering new approaches in the insurance category is expected to drive the segment growth over the forecast period
• The North American region is witnessing an increasing demand for better communication, seamless data sharing, and high integration between insurers and service providers for improved customer engagement

Insurtech Market Segmentation

Grand View Research has segmented the global insurtech market based on type, service, technology, end-use, and region:

Insurtech Type Outlook (Revenue, USD Million, 2016 - 2028)

• Auto
• Business
• Health
• Home
• Specialty
• Travel
• Others

Insurtech Service Outlook (Revenue, USD Million, 2016 - 2028)

• Consulting
• Support & Maintenance
• Managed Services

Insurtech Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Blockchain
• Cloud Computing
• IoT
• Machine Learning
• Robo Advisory
• Others

Insurtech End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Automotive
• BFSI
• Government
• Healthcare
• Manufacturing
• Retail
• Transportation
• Others

Insurtech Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players of Insurtech Market

• Damco Group
• DXC Technology Company
• Insurance Technology Services
• Majesco
• Oscar Insurance
• Quantemplate
• Shift Technology
• Trōv, Inc.
• Wipro Limited
• Zhongan Insurance

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Digital Remittance Market Outlook, Leading Manufacturers, Industry Analysis And Forecast: Grand View Research Inc.

 Digital Remittance Market Growth & Trends

The global digital remittance market size is expected to reach USD 42.46 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 13.3% from 2021 to 2028. The market growth can be attributed to the increasing transfer of money by overseas migrants to their native countries. These money transfers can be done by using digital transfer networks, such as digital wallets and easy-to-use mobile applications.

Various factors, such as ease of usability and reduced user fees related to digital remittance services, are expected to contribute to market growth. Numerous benefits are offered by these services, such as lower cost of the transaction, high payment speed, and convenience, among others. Customers have shifted their focus toward digital transactions for money remittance as these services eliminate the need for tedious form-filling processes.

An increase in cross-border transactions and rapid growth in the adoption of mobile banking are expected to propel the market growth over the forecast period. Numerous banks and online platforms are focusing on lowering transaction fees, thereby creating growth opportunities for market growth. Furthermore, the increasing adoption of digital transfer networks, such as electronic identification, distributed ledgers, digital currencies, and mobile money to remit money, has made cross-border payments easier.

The outbreak of the COVID-19 pandemic is expected to favorably impact the market. Nowadays, numerous consumers across the globe are using digital wallets and online platforms to remit money to their family and friends. The need for global remittances is expected to increase owing to worldwide restrictions on movement.

Request a free sample copy or view report summary: Digital Remittance Market Report

Digital Remittance Market Report Highlights

• The inward digital remittance segment is anticipated to witness significant growth over the forecast period owing to the increasing usage of mobile payment applications for money transfers in developed countries
• Numerous banks across the globe are focusing on integrating technologies into their remittance platforms to provide faster transfer time. Moreover, banks are increasingly adopting digital innovation to achieve a competitive advantage over other competitors. Also, the growing shift toward digitization in the cross-border money transfer industry is expected to drive the segment growth over the forecast period
• The personal end-use segment is expected to continue its dominance over the forecast period since a large number of fund transactions is made by immigrants studying or working in various countries
• In the Asia Pacific region, businesses are increasingly engaging with their overseas counterparts for leisure, business, medical, entertainment, and education-related activities, which include the transfer of money overseas. This, as a result, is expected to drive the regional market growth over the forecast period

Digital Remittance Market Segmentation

Grand View Research has segmented the global digital remittance market based on type, channel, end-use, and region:

Digital Remittance Type Outlook (Revenue, USD Million, 2016 - 2028)

• Inward Digital Remittance
• Outward Digital Remittance

Digital Remittance Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Banks
• Money Transfer Operators
• Online Platforms
• Others

Digital Remittance End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Migrant Labor Workforce
• Personal
• Small Businesses
• Others

Digital Remittance Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players of Digital Remittance Market

• Azimo Limited
• Digital Wallet Corporation
• InstaReM Pvt. Ltd.
• MoneyGram
• PayPal Holdings, Inc.
• Ria Financial Services Ltd.
• TransferGo Ltd.
• TransferWise Ltd.
• Western Union Holdings, Inc.
• WorldRemit Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Durable Medical Equipment Market to Reach Around USD 84.3 Billion by 2028

 U.S. Durable Medical Equipment Market Growth & Trends

The U.S. durable medical equipment market size is expected to reach USD 84.3 billion by 2028, according to a new report published by Grand View Research, Inc. It is projected to expand at a 6.0% CAGR over the forecast period. The rising prevalence of chronic diseases with the rapidly mounting geriatric population requiring long-term care and increasing penetration of home healthcare services & staff are factors driving the demand for Durable Medical Equipment (DME).

The demand for DME is projected to witness a rise during the forecast period, as they are designed per patient acceptance and compliance which boosts its adoption. The aging population and preference for shorter hospital stays are the factors making home healthcare more common. With these trends, a significant number of medical devices such as patient monitoring systems and mobility aids are in great demand.

Furthermore, the current coronavirus pandemic has presented unusual and extraordinary challenges to the healthcare system. As the virus continues to spread, there is an increasing demand for home treatment for several health issues, including those directly or indirectly related to COVID-19. As hospital discharges become more prevalent to manage current resources, the resultant demand and production strain on DME providers especially for home oxygen and ventilator suppliers are projected to increase significantly. The ventilator circuit and other respiratory supplies are on a major supply crunch.

Request a free sample copy or view report summary: U.S. Durable Medical Equipment Market Report

U.S. Durable Medical Equipment Market Report Highlights

• Monitoring and therapeutic devices emerged as the largest segment. It accounted for the largest market share of 89.4% in 2020 owing to the high usage and ease of handling of the products
• The personal mobility devices segment is anticipated to be the fastest-growing segment over the forecast period as these offer custodial care products like door openers, wheelchairs, and scooters
• Moreover, the introduction of advanced walking aids has led to the growth of the personal mobility devices market. An increasing number of disorders, such as spinal cord injuries, osteoporosis, and rheumatoid arthritis is driving the demand for wheelchairs in the U.S.
• The growth of home healthcare as a cost-effective alternative to expensive hospital stay is expected to be a high-impact rendering driver over the forecast period
• Besides, the increase in insured population as a result of the Affordable Care Act is also supporting the market growth within North America

U.S. Durable Medical Equipment Market Segmentation

Grand View Research has segmented the U.S. durable medical equipment market based on product:

U.S. DME Product Type Outlook (Revenue, USD Million, 2016 - 2028)

• Personal Mobility Devices
  • Wheelchairs
  • Scooters
  • Walker & Rollators
  • Canes & Crutches
  • Door Openers
  • Other Devices
• Bathroom Safety Devices & Medical Furniture
  • Commodes & Toilets
  • Mattress & Bedding Devices
• Monitoring & Therapeutic Devices
  • Blood Sugar Monitors
  • Continuous Passive Motion (CPM)
  • Infusion Pumps Market
  • Nebulizers
  • Oxygen Equipment
  • Continuous Positive Airway Pressure (CPAP)
  • Suction Pumps
  • Traction Equipment
  • Other Equipment
    • Insulin Pumps
    • Ostomy Bags & Accessories
    • Wound Care Products
    • Cardiology Devices
    • Vital Signs Monitors
    • Respiratory supplies (APAP/BiPAP)
    • Urinary supplies
    • Diabetic Supplies
    • Incontinence Products
    • Orthopedic braces and support system
    • Muscle Stimulators
    • Others

List of Key Players in the U.S. Durable Medical Equipment Market

• Invacare Corporation
• Sunrise Medical
• ArjoHuntleigh
• Medline Industries, Inc.
• GF Healthcare Products, Inc.
• Carex Health Brands, Inc.
• Cardinal Health
• Drive DeVilbiss Healthcare
• NOVA Medical Products
• Kaye Products, Inc

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sternal Closure Systems Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

 Sternal Closure Systems Market Growth & Trends

The global sternal closure systems market size is expected to reach USD 3.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.6% from 2021 to 2028. The market is driven by the growing number of surgeries undertaken to treat complex cardiovascular problems. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC), around 30.3 million or 12.1% of U.S. adults were diagnosed with heart disease in 2018.

The National Health Interview Survey conducted by CDC in 2016 concluded that 28.1 million people were diagnosed with heart-related disorders including, valvular heart disease, cardiac arrest. Moreover, technological advancements such as Talon systems, double sternal wires, and favorable reimbursement criteria would propel growth in the near future.

Mergers and acquisitions, new product development, and geographical expansion are key sustainability strategies adopted by players in the market. For instance, in December 2020, Zimmer Biomet Holdings Inc., acquired A&E Medical Corporation to gain access to its product portfolio, ensuring long-term growth.

Request a free sample copy or view report summary: Sternal Closure Systems Market Report

Sternal Closure Systems Market Report Highlights

• North America dominated the market in 2020, attributed to the presence of a large number of players and high competitive rivalry in the market
• By product, the closure devices segment held major shares of the market in 2020, owing to the introduction of technologically advanced clips and wires globally and favorable reimbursement regulations offer by developed regions such as North America and Europe
• By procedure, the median sternotomy segment dominated the market in 2020, as it is among the frequently performed osteotomies worldwide
• By material, the PEEK segment is anticipated to post significant growth over the coming years due to several benefits offered by the material, including biocompatibility, chemical resistance, end-product purity, high-temperature resistance, and thermoformable nature

Sternal Closure Systems Market Segmentation

Grand View Research has segmented the global sternal closure systems market based on product, procedure, material, and region:

Sternal Closure Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

• Closure Devices
  • Wires
  • Plates and Screws
  • Clips
  • Cables
• Bone Cement

Sternal Closure Systems Material Outlook (Revenue, USD Million, 2016 - 2028)

• Titanium
• Polyether Ether Ketone (PEEK)
• Stainless Steel
• Others

Sternal Closure Systems Procedure Outlook (Revenue, USD Million, 2016 - 2028)

• Median Sternotomy
• Hemisternotomy
• Bilateral Thoracosternotomy
• Others

Sternal Closure Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Sternal Closure Systems Market

• Zimmer Biomet
• Johnson & Johnson
• Braun Melsungen AG
• Orthofix Holdings, Inc.
• GE Healthcare
• KLS Martin Group
• A&E Medical Corporation
• Jace Medical, LLC
• Acute Innovations
• Abyrx, Inc.
• Kinamed Incorporated

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental X-ray Market to Reach USD 3.35 Billion by 2028

 Dental X-ray Market Growth & Trends

The global dental x-ray market size is expected to reach USD 3.35 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 18.6% from 2021 to 2028. The increasing prevalence of oral diseases as well rising geriatric population are some of the factors that have led to the growth of the market.

Dental x-ray systems are useful in detecting and recording areas of decay that are undetectable by oral examination, especially minor areas of decay present between teeth. The rising prevalence of periodontitis is also accelerating the demand for these instruments. According to the CDC, 47.2% of adults aged 30 years in the U.S. have some form of periodontal disease with the condition being more common in men than women as they are more prone to smoking and health conditions, like diabetes. Other oral diseases contributing to the high demand for dental x-ray units are oral infections, gum diseases, oral cavities, periodontitis, tooth decay, and tumor or cyst detection. Early diagnosis of severe dental problems helps in treating them at the nascent stage, thus leading to potential cost savings.

The geriatric population plays a significant role in the growth of the market. This group of population is highly susceptible to various kinds of oral problems, thus considered to be a lucrative target population for the market. Furthermore, major companies are undertaking initiatives such as new product development. For instance, in 2019, Dentsply Sirona introduced Orthophos Systems 2D/3D extraoral imaging system that allows the practitioners to image, diagnose, and treat (IDT) for higher case acceptance and expand their treatment procedures into implantology, endodontics, etc.

Request a free sample copy or view report summary: Dental X-ray Market Report

Dental X-ray Market Report Highlights

• By product, analog radiographs held the largest market share in 2020 as they are easier to use as compared to digital systems. Digital radiography is anticipated to grow at a significant rate over the forecast period as it is an environmentally friendly technology, requiring no film or chemicals and generating no waste
• Based on type, intraoral x-ray imaging held the largest share in 2020 as it is the most widely used diagnostic method in the field of dentistry. Extraoral imaging is anticipated to register the highest CAGR over the forecast period due to the rising incidence of temporomandibular disorders
• The medical application segment held the largest share in 2020 due to its increasing use in the diagnosis and treatment of diseases of the oral cavity, which includes gums, bone, teeth, and other oral tissues
• In North America, the U.S. held the largest revenue share in 2020 as the country is witnessing a gradual shift toward the incorporation of digital imaging systems
• Asia Pacific is expected to be the fastest-growing regional market over the forecast period owing to the presence of densely populated countries, such as China and India

Dental X-ray Market Segmentation

Grand View Research has segmented the global dental x-ray market on the basis of product, type, application, and region:

Dental X-ray Product Outlook (Revenue, USD Million, 2016 - 2028)

• Analog
• Digital

Dental X-ray Type Outlook (Revenue, USD Million, 2016 - 2028)

• Intraoral
  • Bitewing
  • Periapical
  • Occlusal
• Extraoral
  • Panoramic
  • CBCT
  • Others

Dental X-ray Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
• Cosmetic Dentistry
• Forensic

Dental X-ray Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

List of Key Players of Dental X-ray Market

• Dentsply Sirona Inc.
• Planmeca OY
• Carestream Dental, LLC
• Danaher
• LED Medical Diagnostics, Inc.
• Cefla S.C.
• Vatech Co., Ltd.
• Yoshida Dental Mfg. Co. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Veterinary Active Pharmaceutical Ingredients Manufacturing Market During 2021– 2028 to Gain Robust Traction

 Veterinary API Manufacturing Market Growth & Trends

The global veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 10.4 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.9% over the forecast period. The increasing prevalence of chronic diseases in animals and growing concerns among pet owners are the key contributors to the market growth.

Moreover, the growing prevalence of zoonotic diseases is driving the demand for drugs, which, in turn, boosts the demand for active pharmaceutical ingredients (APIs) for the production of these drugs. According to the Centers for Disease Control and Prevention (CDC), in July 2017, it was estimated that 6 out of 10 known infectious diseases in people can be transmitted from animals and 3 out of every 4 novel or emerging infectious diseases in people are caused due to animals.

Government organizations are involved in issuing various guidelines to promote veterinary services globally, which is expected to contribute to market growth in the coming years. For instance, in May 2018, the OIE International Standards, a part of the WTO framework, issued standards to improve animal health, which will affect human health as well. One of the key challenges was found to be the lack of technical expertise in this field.

The rising number of veterinarians is also anticipated to boost the market growth. According to the American Veterinary Medical Association, in 2018, there were 113,394 veterinarians in the U.S. as compared to 110,531 veterinarians in 2017. Out of these, 48,898 were involved in private clinical practice exclusively for companion animals. Also, according to the Canadian Veterinary Medical Association (CVMA), the approximate number of veterinarians in Canada is 12,921.

Request a free sample copy or view report summary: Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report

Veterinary API Manufacturing Market Report Highlights

• The contract outsourcing service type accounted for the largest revenue share of over 58% in 2020 owing to associated benefits with its usage
• The growing number of outsourcing activities by pharmaceutical companies is expected to boost the segment growth
• Chemical-based API synthesis type dominated the market in 2020. This can be attributed to its high usage by many major manufacturing companies
• The vaccines product segment held the largest market share of over 23% in 2020 due to increased demand for vaccines as a result of a high prevalence of chronic diseases in animals
• Due to the presence of well-established companies and technologically advanced infrastructure, North America dominated the market in 2020
• However, Asia Pacific is anticipated to register the fastest CAGR over the forecast period owing to the high potential and rapidly growing markets of India, Japan, and China
• Industry players are involved in strategies including mergers & acquisitions, collaborative agreements, and geographic expansions to gain a competitive edge
• For instance, in March 2020, SeQuent Scientific Ltd. received WHO-GENEVA approval for API Praziquantel, which is an anti-helminthic, under pre-qualification program in its Vizag, India facility

Veterinary API Manufacturing Market Segmentation

Grand View Research has segmented the global veterinary active pharmaceutical ingredients manufacturing market on the basis of service type, synthesis type, product, and region:

Veterinary API Manufacturing Service Type Outlook (Revenue, USD Million, 2016 - 2028)

• In House
• Contract Outsourcing
  • Contract Development
    • Preclinical Development
    • Others
  • Contract Manufacturing
    • API/Bulk Drugs
    • Finished Dose Formulations

Veterinary API Manufacturing Synthesis Type Outlook (Revenue, USD Million, 2016 - 2028)

• Chemical-based API
• Biological API
• HPAPI

Veterinary API Manufacturing Product Outlook (Revenue, USD Million, 2016 - 2028)

• Antiparasitic
• Anti-infectives
• NSAIDs
• Vaccines
• Biologics
• Others

Veterinary API Manufacturing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa

List of Key Players of Veterinary API Manufacturing Market

• Alivira Animal Health Ltd.
• Excel Industries Ltd.
• Ofichem Group
• Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
• Menadiona
• Afton Pharma
• Jiangsu Lingyun Pharmaceutical Co., Ltd.
• SUANFARMA
• NGL Fine-Chem Ltd.
• FIS - Fabbrica Italiana Sintetici S.p.A

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wearable Medical Devices Market to Expand at a CAGR of 26.8% Through 2028

 Wearable Medical Devices Market Growth & Trends

The global wearable medical devices market size is expected to reach USD 111.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 26.8% from 2021 to 2028. Rising demand for hi-tech products and continuous health monitoring is fueling market growth.

Increasing obesity rate coupled with rising awareness about physical fitness is encouraging people to go for workouts and adopt other fitness-related activities. Wearable devices such as smart bands and smartwatches help in monitoring fitness parameters consisting of calories burned, footstep count, heart rate and distance covered. Moreover, these wearable devices companies offer guidance from experts who are certified dietician or nutrition, and hence, this business model is also generating hefty demand for these ancillary products and services.

Companies such as Google, Fitbit, Apple, and Nike are working towards the launch of new innovative products that are anticipated to boost market growth over the forecast period, thus portraying a high growth rate. Smart watches and wristbands are the current focal point of product development and innovation, leading to abundant availability of such instruments. For instance, HealthPatch, a product of Vital Connect, was launched in March 2014. The product is an adhesive patch that can be placed anywhere on the chest and is used to regulate biometrics such as heart rate, skin temperature, body posture, and activities like steps walked.

The COVID-19 pandemic somehow has a positive impact on the market owing to increasing demand for telemedicine. As per the WHO guidelines people should follow social distancing and avoid public gathering. Hence due to this reason various physicians are preferring telemedicine route so that they can treat patients from distance without spreading the virus. Growth of telemedicine and expansion of applications to Integrate artificial intelligence (AI) in its systems has led to market growth.

Request a free sample copy or view report summary: Wearable Medical Devices Market Report

Wearable Medical Devices Market Report Highlights

• The diagnostic devices segment dominated the market in 2020 owing to the increasing disposable income and awareness, and higher healthcare spending
• The strap/clip/bracelet segment dominated the market in 2020 and is expected to continue its dominance over the forecast period
• Home healthcare held a significant share of 54.0% in 2020 owing to the growing base of geriatric population triggering incidence rates of target diseases
• North America is projected to command for a cumulative share in 2020 due to the increasing application of home care and remote patient monitoring for the purpose of regular, continuous, and long-term monitoring of patients
• Asia Pacific is expected to witness the fastest growth rate over the forecast period. This growth can be attributed to the growing awareness level, increasing disposable income, presence of a large population base and rising incidence rate of chronic conditions

Wearable Medical Devices Market Segmentation

Grand View Research has segmented the global wearable medical devices market based on product, site, application, and region:

Wearable Medical Devices Product Outlook (Revenue, USD Billion, 2016 - 2028)

• Diagnostic Devices
  • Vital Sign Monitoring Devices
    • Heart Rate Monitors
    • Activity Monitors
    • Electrocardiographs
    • Pulse Oximeters
    • Spirometers
    • Blood Pressure Monitors
    • Others
  • Sleep Monitoring Devices
    • Sleep trackers
    • Wrist Actigraphs
    • Polysomnographs
    • Others
  • Electrocardiographs Fetal And Obstetric Devices
  • Neuromonitoring Devices
    • Electroencephalographs
    • Electromyographs
    • Others
  • Therapeutic Devices
    • Pain Management
      • Neurostimulation
      • Others
    • Insulin/Glucose Monitoring
      • Insulin Pumps
      • Others
    • Rehabilitation
      • Accelometers
      • Sensing
      • Ultrasound Platform
      • Others
    • Respiratory Therapy
      • Ventilators
      • Positive Airway Pressure (PAP) Devices
      • Portable Oxygen Concentrators
      • Others

Wearable Medical Devices Site Outlook (Revenue, USD Billion, 2016 - 2028)

• Handheld
• Headband
• Strap/Clip/Bracelet
• Shoe Sensors
• Others

Wearable Medical Devices Application Outlook (Revenue, USD Billion, 2016 - 2028)

• Sports And Fitness
• Remote Patient Monitoring
• Home Healthcare

Wearable Medical Devices Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • France
  • Germany
  • UK.
  • Italy
  • Spain
  • Sweden
  • Russia
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Thailand
  • Philippines
  • Malaysia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Wearable Medical Devices Market

• Philips Electronics
• Fitbit
• Basis Science
• Garmin
• Covidien
• Omron Corp.
• Withings
• Vital Connect
• Polar Electro
• Intelesens
• Everist Genomics
• Intelesens
• Sotera Wireless

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-invasive Prenatal Testing Market Outlook, Leading Manufacturers, Industry Analysis And Forecast

 Non-invasive Prenatal Testing Market Growth & Trends

The global non invasive prenatal testing market size is anticipated to reach USD 6.5 billion by 2028 registering a CAGR of 10.9%, according to a new report by Grand View Research, Inc. High adoption and demand for early non-invasive prenatal testing (NIPT) coupled with improvements in reimbursement scenario are among the factors driving the market.

The use of invasive techniques of prenatal testing, such as chorionic villus sampling and amniocentesis, can lead to issues, such as miscarriage. This has led to a decline in the use of these procedures and high demand for tests that are more efficient, non-invasive, and safe. Furthermore, non-invasive fetal tests have a lower failure and false-positive rate, which has resulted in a considerable increase in uptake of non-invasive tests in the last few years.

The non-invasive prenatal testing market is highly saturated with the existing key players. Companies are forming partnerships and collaborations to maintain a stable position in the market. For instance, in August 2020, Eurofins Scientific announced an agreement with Noritsu Koki Co., Ltd. for the acquisition of GeneTech Inc., one of the pioneering NIPT developers in Japan. With this acquisition, Eurofins Scientific is set to strengthen its presence in the Japanese NIPT market.

Request a free sample copy or view report summary: Non-invasive Prenatal Testing Market Report

Non-invasive Prenatal Testing Market Report Highlights

• The 13-24 weeks gestation period segment accounted for the largest revenue share in 2020 owing to the presence of a maximum number of tests carried out in this phase of pregnancy
• NIPT for high- & average-risk pregnancy led the market owing to the presence of favorable payer reimbursement policies in this segment
• Next-Generation Sequencing(NGS) is estimated to be the largest as well as the fastest-growing technology segment from 2021 to 2028, as NGS is the most commonly used method for NIPT
• The diagnostic laboratories end-use segment held the largest revenue share in 2020 and will expand further at the fastest CAGR from 2021 to 2028 due to the rising number of diagnostic laboratories across the globe that offer NIPT
• Asia Pacific is expected to register the fastest year-on-year growth owing to the gradually increasing average maternal age and rising incidence of chromosomal aneuploidies
• One of the key trends followed by market participants includes licensing of the test to other labs and generating significant revenue by collecting royalty payments

Non-invasive Prenatal Testing Market Segmentation

Grand View Research has segmented the global non-invasive prenatal testing market on the basis of the gestation period, risk type, method, technology, product, end-use, and region:

NIPT Gestation Period Outlook (Revenue, USD Million, 2017 - 2028)

• 0-12 Weeks
• 13-24 Weeks
• 25-36 Weeks

NIPT Risk Type Outlook (Revenue, USD Million, 2017 - 2028)

• High & Average Risk
• Low Risk

NIPT Method Outlook (Revenue, USD Million, 2017 - 2028)

• Ultrasound Detection
• Biochemical Screening Tests
• Cell-Free DNA in Maternal Plasma Tests

NIPT Technology Outlook (Revenue, USD Million, 2017 - 2028)

• NGS
• Array Technology
• PCR
• Other Technologies

NIPT Product Outlook (Revenue, USD Million, 2017 - 2028)

• Consumables & Reagents
• Instruments

NIPT End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Hospitals & Clinics
• Diagnostic Laboratories

NIPT Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Non-invasive Prenatal Testing Market

• Genesis Genetics (CooperSurgical, Inc.)
• Natera, Inc.
• Centogene N.V.
• Illumina, Inc. (Verinata Health, Inc.)
• Eurofins LifeCodexx GmbH
• MedGenome Labs Ltd.
• Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
• Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.)
• Progenity, Inc.
• Qiagen
• Laboratory Corp. of America Holdings
• Quest Diagnostics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

DNA & RNA Banking Services Market Is Expected To Accomplish A Valuation Of Around USD 8.83 Billion By 2027: Grand View Research Inc.

 DNA & RNA Banking Services Market Growth & Trends

The global DNA and RNA banking services market size is expected to reach USD 8.83 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.46% from 2021 to 2027. Biospecimens such as DNA and RNA are critical for biomarker discovery, thereby providing a path for the expansion of personalized medicine. Moreover, progress in translational and clinical research through an introduction of advanced, standardized cell isolation methodologies reduces hands-on-time. The development of automated solutions and the transformation of biobanks into fully automated biobanks potentially accelerate the growth of the market.

A rise in the enrollment of individuals for personalized medicine initiatives drives the revenue generation for DNA and RNA banking services. In July 2019, Partners HealthCare, U.S. enrolled more than 100,000 individuals in its precision medicine biobank that supported clinicians and researchers of the Brigham and Women’s Hospital, U.S., and other partners. Such initiative assisted in examining the impact of several factors on disease and health.

The distribution network is continuously becoming complex, with pharmaceutical firms facing new challenges related to sustainability initiatives, regulatory adherence, and competing priorities cost pressures. The efforts undertaken by the key players to invest in the cold chain storage and expansion of distribution capability in various geographies have increased the capability to handle large quantities of complex cold chain biologics. Key companies such as EasyDNA, DNA Genotek, 23andMe, GoodCell, ProteoGenex., and US Biolab have adopted several strategic alliances to reinforce their market presence. 

Request a free sample copy or view report summary: DNA & RNA Banking Services Market Report

DNA & RNA Banking Services Market Report Highlights

• By service type, storage services accounted for the largest revenue share in 2020 owing to the presence of numerous key providers in the market space. The advent of automated sample storage systems and automated liquid handlers to manage large sample volume, and reduce the amount of time required to process, store, and distribute samples further drives the segment
• Based on specimen type, the blood segment dominated the market in 2020 owing to fast and quick procedures of collecting blood, minimal risk of contamination, and visibility of blood samples
• In terms of application, the drug discovery and clinical research segment held the largest share in 2020. Biobanking services are utilized to accelerate the discovery of new therapeutics and offer resources for future investigations to better understand the effects of environmental, genetic, and lifestyle factors on human health, morbidity, and mortality. This factor led to the maximum revenue share of the segment
• On the basis of end use, the hospitals and diagnostic centers segment is projected to witness the fastest growth throughout the forecast period owing to the efforts undertaken by government bodies and biobanks to broaden the accessibility for DNA and RNA samples in the hospitals and diagnostic centers for COVID-19 diagnosis
• North America accounted for the largest revenue share in 2020. One of the major factors positively accelerating market growth is the initiation of national precision-medicine initiatives, such as the “All of Us” biobank in the U.S.

DNA & RNA Banking Services Market Segmentation

Grand View Research has segmented the global DNA and RNA banking services market on the basis of service type, specimen type, application, end-use, and region:

DNA & RNA Banking Service Type Outlook (Revenue, USD Million, 2016 - 2027)

• Transportation Service
• Processing Service
• Storage Service
• Quality Control Service
• Data Storage
• Others

DNA & RNA Banking Services Specimen Type Outlook (Revenue, USD Million, 2016 - 2027)

• Blood
• Buccal Swabs & Hair Follicles
• Others

DNA & RNA Banking Services Application Outlook (Revenue, USD Million, 2016 - 2027)

• Therapeutics
• Drug Discovery & Clinical Research
• Clinical Diagnostics
• Other Applications

DNA & RNA Banking Services End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Academic Research
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Others

DNA & RNA Banking Services Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of DNA & RNA Banking Services Market

• EasyDNA
• DNA Genotek Inc.
• 23andMe, Inc.
• GoodCell
• US Biolab Corporation, Inc.
• Infinity Biologix
• Thermo Fisher Scientific, Inc.
• deCODE genetics
• Brooks Life Sciences
• LGC Biosearch Technologies
• PreventionGenetics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopharmaceuticals Contract Manufacturing Market is Estimated to Register at a CAGR of 5.7% During The Forecast Period

 

Biopharmaceuticals Contract Manufacturing Market Growth & Trends

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7%, according to a new report by Grand View Research, Inc. Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs). Contract manufacturers are engaged in broadening their service portfolio to meet the company demands with respect to regulatory standards and new services.

The reliance of companies on CMOs for the production of biologics and biosimilars is expected to rise over the forecast period as a consequence of changes adopted by the CMOs. This is evident through growing investment in collaborations of companies with CMOs as well as continuous efforts taken up for expanding the service portfolio.

The supply chain of biopharmaceuticals remained robust and was largely unaffected worldwide during the coronavirus outburst. Also, biopharmaceutical contract manufacturers are observing increased demand related to the Covid-19 vaccine and therapeutics. Thus, the future holds numerous opportunities for the global market. For instance, in 2020, AstraZeneca and Oxford Biomedica signed a one-year clinical and commercial supply agreement for the manufacturing of AstraZeneca’s Covid-19 vaccine candidate, AZD1222.

The future growth of CMOs is highly dependent on the promising opportunities offered by the biopharmaceutical industry, the bioprocessing industry, and the contract service industry. Expansion of fill-and-finish services and increasing robustness of venture capital investments for the life science sector are two important opportunities that are anticipated to drive the market. For instance, in 2019, Shanghai HaiHe Biopharma Co. Ltd. raised USD 146.6 million as venture capital for its large cancer drug portfolio, which they shall utilize along with their outsourcing partner Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Request a free sample copy or view report summary: Biopharmaceuticals Contract Manufacturing Market Report

Biopharmaceuticals Contract Manufacturing Market Report Highlights

• Mammalian-based biopharmaceutical contract manufacturing captured the largest market share of over 59% in 2020 owing to the high penetration of mammalian expression system for biologics development
• Out of all the services offered in this market, process development contributed to the largest share in 2020 owing to high capital investment, especially in the downstream process
• The complexities associated with regulatory approval and good manufacturing practice pronounces the demand for the established contract manufacturers to ensure compliance with regulatory standards
• The biologics contract manufacturing segment dominated the global market in 2020 owing to higher demand for biologics production
• However, the biosimilar segment is estimated to register the fastest CAGR from 2021 to 2028 due to cost-saving advantages associated with biosimilars development
• North America was the dominant regional market in 2020 due to the presence of an effective regulatory framework for biologics development in the U.S.
• However, Asia Pacific is expected to emerge as the fastest-growing regional market from 2021 to 2028 owing to emerging countries, such as India and China, incorporating developments to sustain the competition
• Several international companies are seeking outsourcing of biopharmaceutical production to Asian countries owing to the continuous expansion of Asian CMOs that offer services at a less price, as compared to the service providers based in western countries

Biopharmaceuticals Contract Manufacturing Market Segmentation

Grand View Research has segmented the global biopharmaceuticals contract manufacturing market on the basis of source, service, product, and region:

Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2016 - 2028)

• Mammalian
• Non-mammalian

Biopharmaceuticals Contract Manufacturing Service Outlook (Revenue, USD Million, 2016 - 2028)

• Process Development
  • Downstream
  • Upstream
• Fill & Finish Operations
• Analytical & QC Studies
• Packaging

Biopharmaceuticals Contract Manufacturing Product Outlook (Revenue, USD Million, 2016 - 2028)

• Biologics
  • Monoclonal Antibodies (MABs)
  • Recombinant Proteins
  • Vaccines
  • Antisense, RNAi, & Molecular Therapy
  • Others
• Biosimilars

Biopharmaceuticals Contract Manufacturing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in Biopharmaceuticals Contract Manufacturing Market

• Boehringer Ingelheim GmbH
• Lonza
• Inno Biologics Sdn Bhd
• Rentschler Biotechnologie GmbH
• JRS Pharma
• AGC Biologics
• ProBioGen
• Fujifilm Diosynth Biotechnologies U.S.A., Inc.
• Toyobo Co., Ltd.
• Samsung BioLogics
• Thermo Fisher Scientific, Inc.
• Binex Co., Ltd.
• WuXi Biologics
• AbbVie, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Bioprinting Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

• The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D
• The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators
• North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market on the basis of technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Inkjet-based
• Magnetic Levitation
• Syringe-based
• Laser-based
• Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
  • Tissue and organ generation
  • Medical pills
  • Prosthetics and implants
• Dental
• Biosensors
• Consumer/Personal Product Testing
• Bioinks
• Food and Animal Product

3D Bioprinting Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of 3D Bioprinting Market

• Envisiontec, Inc.
• Organovo Holdings, Inc.
• Inventia Life Science PTY LTD
• Poietis
• Vivax Bio, LLC
• Allevi
• Cyfuse Biomedical K.K.
• 3D Bioprinting Solutions
• Cellink Global
• Regemat 3D S.L.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Bottled Water Market Trends And Forecast 2021-2028: Grand View Research Inc.

 Bottled Water Market Growth & Trends

The global bottled water market size is expected to reach USD 505.19 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.1% from 2021 to 2028. The growing awareness regarding the adverse health effects of consuming sugary drinks, such as weight gain, obesity, diabetes, and heart disease, is supporting the consumption of alternative beverages, such as still and sparkling water.

The growth of the market is primarily attributed to rising awareness regarding the importance of hydration. According to a study conducted by the International Bottled Water Association in 2018, it was revealed that 93% of American citizens want bottled water to be sold in most stores selling beverages. A substantial part of the population prefers to quench their thirst using bottled water over other beverages.

Increasing preference for nutrient-fortified water is trending owing to the rising importance of health and wellness among buyers. The water demand has been increasing among travelers, working professionals, and for use in households.

COVID-19 has impacted the market for bottled water as many quick-service restaurants have been witnessing a significant drop in their sales. For instance, according to a blog post by CNBC LLC, McDonald’s had witnessed a decline of 22% in March compared to the previous month. COVID-19 compelled the company to shut down its dining rooms.

Request a free sample copy or view report summary: Bottled Water Market Report

Bottled Water Market Report Highlights

• The inclination toward packaged water rather than ordinary water, particularly among younger consumers, drives product sales. Observing this trend, several restaurants are providing bottled water to meet consumer demand
• The purified water segment held the largest share of more than 35.0% in 2020. According to a United Nations study published in 2018, there are almost 16,000 desalination plants across 177 countries that provide purified water
• The sparkling water segment is anticipated to be the fastest-growing segment with a CAGR of 11.7% from 2021 to 2028. Sparkling water is also marketed as sparkling drinking water or sparkling mineral water. Water that contains the same amount of carbon dioxide as its source post-treatment is defined as sparkling water
• Asia Pacific held the largest market share in 2020 and is expected to maintain its lead throughout the forecast period. The regional market is mainly driven by the growing preference for bottled water owing to rising health issues caused by the consumption of contaminated water in countries, including China and India

Bottled Water Market Segmentation

Grand View Research has segmented the global bottled water market on the basis of product and region:

Bottled Water Product Outlook (Revenue, USD Million, 2016 - 2028)

• Spring
• Purified
• Mineral
• Distilled
• Sparkling
• Others

Bottled Water Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
• Europe
  • Germany
  • France
• Asia Pacific
  • China
  • India
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Bottled Water Market

• Nestlé SA
• PepsiCo
• The Coca-Cola Company
• DANONE
• Primo Water Corporation
• FIJI Water Company LLC.
• Gerolsteiner Brunnen GmbH & Co. KG
• VOSS WATER
• Nongfu Spring
• Rhodius Mineralquellen Und Getranke GmbH & Co KG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Digital Pathology Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

 North America Digital Pathology Market Growth & Trends          

The North America digital pathology market size is expected to reach USD 593.9 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.

The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past years. The increasing need for lowering healthcare costs, increasing importance of big data in healthcare, rising adoption of precision medicine, and declining hardware costs are some factors driving the growth. In addition, increasing usage of artificial intelligence-based analytical tools in healthcare and high capital investments in this field are further propelling the market growth.

During the coronavirus outbreak, the exponential need for home-based workstations and safe clinical informatics systems allowing healthcare professionals to read images remotely and enabling virtual collaboration between their multi-disciplinary care teams has increased. Various histopathology departments in the region faced a reducing workforce and increasing workload during the pandemic. Digital pathology considered being the potential solution for some of the challenges faced by the pathologist, there is an increase in the adoption of digital diagnosis of disease during coronavirus outbreak.

In April 2020, Philips announced that the FDA granted a waiver for home use of consumer monitors with the company's IntelliSite Pathology Solution during the emergency. The temporary exemption of restrictions on remote use of the digital pathology helps pathologists to access whole slide images from home and fasten the diagnosis of histology cases. Some pathology labs that have adopted DP in their workflows across different sites pre-COVID-19, reported improved collaboration, and an average productivity gain of 21.0% with operation efficiency increased by 13.0%. These types of initiatives are anticipated to fuel market growth.

Request a free sample copy or view report summary: North America Digital Pathology Market Report

North America Digital Pathology Market Report Highlights

• The software segment is anticipated to witness a lucrative growth rate of 6.8% in the coming years. The segment is inclusive of pathology workflow management solution and LIMS software
• This software is simple to install and use, easy to obtain specific patient information, and efficiently and quickly sends reports digitally to pathologists and clinicians. Owing to these associated advantages the software segment is expected to witness lucrative growth over the forecast period
• The practice of sharing digital imagery across labs helps in accelerating drug discovery and development processes by enabling pathologists to effectively analyze records and communicate and collaborate on crucial result findings in tissue-based efficacy studies
• The disease diagnosis segment is projected to witness a significant CAGR of 7.0% in the coming years as the FDA approved the practice of sharing digital imagery across labs for primary diagnosis applications such as cancer cell detection
• Diagnostic laboratories are expected to witness lucrative growth of 7.1% over the forecast period owing to the rising incidence of cancer in this region. Moreover, the implementation of digital pathology solutions and devices is likely to help improve laboratory workflow efficiency, accuracy, and quality of disease diagnosis using computational pathology
• Competitive rivalry in the market is expected to remain high over the forecast period. The market is dominated by few players such as Philips and Leica Biosystems that hold a majority of the revenue
• The strategies implemented by these players are product differentiation, new product launch, collaboration, merger, and acquisition to gain a larger share of the market

North America Digital Pathology Market Segmentation

Grand View Research has segmented the North America digital pathology market on the basis of the product, application, end use, and country:

North America Digital Pathology Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Device

North America Digital Pathology Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Discovery & Development
• Academic Research
• Disease Diagnosis
  • Cancer Cell Detection
  • Others

North America Digital Pathology End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Cancer Hospitals
• Diagnostic Labs
• Academic & Research Institutes

North America Digital Pathology Country Outlook (Revenue, USD Million, 2016 - 2028)

• US.
• Canada

List of Key Players of North America Digital Pathology Market

• Leica Biosystems
• Hamamatsu Photonics, Inc.
• Koninklijke Philips N.V.
• Hoffmann-La Roche Ltd
• Mikroscan Technologies
• 3DHISTECH Ltd.
• Inspirata, Inc.
• Visiopharm A/S
• Huron Technologies International, Inc.
• Sectra AB

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Contract Manufacturing Market Strong Application and Emerging Trends also Scope by 2028: Grand View Research Inc.

 Healthcare Contract Manufacturing Market Growth & Trends

The global healthcare contract manufacturing market size is expected to reach USD 323.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.7% from 2021 to 2028. The changing regulatory landscape, coupled with rising offshoring to emerging countries, is anticipated to propel the market growth over the forecast period.

Increasing demand for advanced products is a major factor driving the market. Original equipment manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly to developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions, such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Moreover, the growing geriatric population across the globe and the consequent rise in age-related diseases have stimulated the progress of pharmaceutical and medical device development, thus leading to the growth of the healthcare manufacturing industry. With a rise in demand, the market now witnesses an influx of manufacturing service providers. Asia Pacific was the dominant regional market for medical device outsourcing in 2020 owing to lower cost and easy availability of skilled human resources. For instance, according to IBEF, M&A deals in the healthcare sector in India increased by 155% (USD 1.09 billion) in 2019.

A rise in the number of medical device companies vying to enter regional markets, such as India and China, is further expected to contribute to the growth of this market. For instance, the Chinese government’s Marketing Authorization Holder (MAH) scheme facilitates international healthcare players to produce their products within the local Chinese market equipped with state-of-the-art centers. The expansion of production capacity by players such as WuxiBiologics is a distinguished example of this deliberate plan.

Due to the emergence of infections, such as COVD-19, many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on a large scale. Hence, we can say that the pandemic has had a positive impact on this industry.

This paradigm shift from in-house manufacturing to contract manufacturing in the pharmaceutical and medical device industry has resulted in the increased focus of the companies on contract manufacturing service vendors. These services have effectively addressed the concerns regarding pharmaceutical and medical device manufacturing as well as significantly accelerated the commercialization of products.

Request a free sample copy or view report summary: Healthcare Contract Manufacturing Market Report

Healthcare Contract Manufacturing Market Report Highlights

• By type, the pharmaceutical segment dominated the market with a share of 75.2% in 2020 owing to low manufacturing budget and highly sophisticated contract manufacturing service offerings
• The medical device type segment is expected to be the fastest-growing segment with a CAGR of 9.7% over the forecast period owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
• Cardiology was the dominant therapeutic area segment in the medical device contract manufacturing market in 2020 owing to rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions
• Asia Pacific dominated the market in 2020 and is expected to witness the fastest growth over the forecast period owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region

Healthcare Contract Manufacturing Market Segmentation

Grand View Research has segmented the global healthcare contract manufacturing market based on type and region:

Healthcare Contract Manufacturing Type Outlook (Revenue, USD Billion, 2016 - 2028)

• Medical Device        
  • By Service
    • Accessories Manufacturing
    • Assembly Manufacturing
    • Component Manufacturing
    • Device Manufacturing
  • By Therapeutic Area
    • Cardiology
    • Diagnostic Imaging
    • Orthopedic
    • IVD
    • Ophthalmic
    • General & Plastic Surgery
    • Drug Delivery
    • Dental
    • Endoscopy
    • Diabetes Care
    • Others
  • Pharmaceutical
    • By Service
      • API/Bulk Drugs
      • Advanced Drug Delivery Formulations
      • Packaging
      • Finished Dose Formulations
        • Solid
        • Liquid
        • Semi-solid Formulations

Healthcare Contract Manufacturing Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Belgium
  • Netherlands
  • Switzerland
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Malaysia
  • Singapore
  • Thailand
  • Taiwan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Israel

List of Key Players of Healthcare Contract Manufacturing Market

• Nordson Corporation
• Integer Holdings Corporation
• Jabil Inc.
• Viant Technology LLC
• FLEX LTD.
• Celestica Inc.
• Sanmina Corporation
• Plexus Corp.
• Phillips-Medisize
• Synecco
• Catalent, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.